Nasser, Azmi
Liranso, Tesfaye
Adewole, Toyin
Fry, Nicholas
Hull, Joseph T.
Chowdhry, Fatima
Busse, Gregory D.
Cutler, Andrew J.
Jones, Nandita Joshi
Findling, Robert L. https://orcid.org/0000-0002-7654-5782
Schwabe, Stefan
Funding for this research was provided by:
Supernus Pharmaceuticals
This article is maintained by: Elsevier
Article Title: A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children
Journal Title: Clinical Therapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinthera.2020.05.021
Content Type: article
Copyright: © 2020 The Authors. Published by Elsevier Inc.